Sana Biotechnology, Inc. (SANA)

Sana Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	137.35	182.87	253.03	126.95	81.81	31.45
Short-Term Investments	71.68	247.2	297.97	253.46	58.95	0
Cash & Cash Equivalents	209.03	430.06	551	380.41	140.76	31.45
Cash Growth	-51.40%	-21.95%	44.84%	170.25%	347.62%	-
Other Current Assets	4.49	14.37	7.11	4.06	3.5	1.15
Total Current Assets	213.52	444.44	558.1	384.47	144.26	32.6
Property, Plant & Equipment	145.59	159.4	161.78	109.94	68.81	0.59
Long-Term Investments	0	14.46	204.7	33.73	0	0
Goodwill and Intangibles	199.82	199.82	199.82	199.82	199.82	0
Other Long-Term Assets	6.37	4.6	5	2.33	2.3	1.15
Total Long-Term Assets	351.78	378.28	571.31	345.83	270.93	1.74
Total Assets	565.3	822.72	1,129	730.3	415.19	34.33
Accounts Payable	4.11	2.86	2.22	2.25	0	0.29
Current Debt	13.2	12.39	9.16	3.71	1.34	0
Other Current Liabilities	47.18	96.25	87.86	25.49	17.98	1.5
Total Current Liabilities	64.49	111.5	99.24	31.45	19.32	1.79
Long-Term Debt	90.9	95.86	101.78	68.2	46.36	0
Other Long-Term Liabilities	122.41	116.04	199.89	198.94	74.69	0.02
Total Long-Term Liabilities	213.31	211.9	301.67	267.13	121.05	0.02
Total Liabilities	277.79	323.41	400.91	298.58	140.38	1.8
Total Debt	104.1	108.25	110.94	71.91	47.7	0
Debt Growth	-3.84%	-2.42%	54.28%	50.75%	-	-
Retained Earnings	-1,338.09	-1,054.84	-785.36	-429.43	-144.13	-13.25
Comprehensive Income	-0.06	-4.33	-1.37	0.03	0.03	0
Shareholders' Equity	287.51	499.32	728.5	-421.18	-142.54	-13.19
Net Cash / Debt	104.93	321.81	440.05	308.5	93.06	31.45
Net Cash / Debt Growth	-67.39%	-26.87%	42.64%	231.51%	195.93%	-
Net Cash Per Share	0.54	1.71	2.64	23.71	18.98	33.03
Working Capital	149.03	332.93	458.87	353.02	124.94	30.81
Book Value Per Share	1.48	2.65	4.38	-32.36	-29.07	-13.85

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).